Evidence map›Paper›PMID 35676559›Full record

ReviewAesthetic plastic surgery2022

Role of Cultured Skin Fibroblasts in Regenerative Dermatology.

Mohammad Ali Nilforoushzadeh, Ebrahim Khodaverdi Darian, Hamideh Afzali, Mohammad Amir Amirkhani, Mohammadreza Razzaghi, Reza Naser, Amir Behtash Amiri, Alimohammad Alimohammadi, Nahid Nikkhah, Sona Zare

Abstract readReview
PubMed Publisher
In one paragraph

Review in Aesthetic plastic surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Mohammad Ali NilforoushzadehSkin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Ebrahim Khodaverdi DarianDepartment of Medical Biotechnology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
Hamideh AfzaliSkin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Amir AmirkhaniSkin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Mohammadreza RazzaghiLaser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Reza NaserDepartment of Tissue Engineering, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Amir Behtash AmiriSkin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Alimohammad AlimohammadiForensic Medicine Specialist, Research Center of Legal Medicine Organization of Iran, Tehran, Iran.
Nahid NikkhahSkin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Sona ZareSkin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran. sonazarebio@gmail.com.ORCID 0000-0002-3109-6717
Tehran University of Medical Sciences · IRBiotechnology Research Center · IRIranian Legal Medicine Organization · IRShahid Beheshti University of Medical Sciences · IRStem Cell Technology Research Center · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The skin, as the largest organ, covers the entire outer part of the body, and since this organ is directly exposed to microbial, thermal, mechanical and chemical damage, it may be destroyed by factors such as acute trauma, chronic wounds or even surgical interventions. Cell therapy is one of the most important procedures to treat skin lesions. Fibroblasts are cells that are responsible for the synthesis of collagen, elastin, and the organization of extracellular matrix (ECM) components and have many vital functions in wound healing processes. Today, cultured autologous fibroblasts are used to treat wrinkles, scars, wounds and subcutaneous atrophy. The results of many studies have shown that fibroblasts can be effective and beneficial in the treatment of skin lesions. On the other hand, skin substitutes are used as a regenerative model to improve and regenerate the skin. The use of these alternatives, restorative medicine and therapeutic cells such as fibroblasts has tremendous potential in the treatment of skin diseases and can be a new window for the treatment of diseases with no definitive treatment. NO LEVEL ASSIGNED: This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description ofthese Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Indexed as

DermatologyAnimalsCadaverFibroblastsSkinWound HealingAutologousCell therapyFibroblastSkinSkin diseases

Identifiers

PMID35676559
OpenAlexW4281828311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.